The capital distribution for the week of October 13 is stark. While AI remains the most active sector by volume, it is being fundamentally out-raised by Health, creating a scenario where AI founders are fighting for smaller slices of a larger pie.
With 25 rounds, AI is the engine of activity, yet it captured only $359M. In contrast, Health secured $540M with just 6 rounds. This represents a massive disparity in conviction and check size, placing significant pressure on AI companies to prove scalable unit economics while Health firms command premium valuations.
Capital Concentration
The data reveals that Health is the primary driver of high-value funding. A single Series C for OMass Therapeutics reached €275 million, signaling that investors are prioritizing deep-tech health breakthroughs over the broad-base AI expansion seen in the 25 smaller AI deals.
The Biggest Rounds
- OMass Therapeutics — €275 Million
- Voltus — $225 Million
- Soufflé — $135M
- Nouscom — €120 million
- Labelbox — $100M
- Suki — $90 million
What founders can do
- AI Founders: Pivot the narrative from general utility to specialized, high-value industry applications to attract the larger check sizes currently flowing into Health.
- Health Founders: Leverage the current appetite for high-ticket Series B and C rounds to secure long-term runways while the sector leads in capital efficiency.